3rd Donor Selection & Cell Source Summit
Returning for its third year, the Donor Selection & Cell Source Summit is the only industry-dedicated forum focused exclusively on the strategic and scientific challenges of donor selection and cell sourcing for allogeneic therapies.
This summit brings together leading minds from biopharma, blood banks, apheresis providers, and cell therapy innovators to address one of the most critical bottlenecks in the development of scalable, off-the-shelf treatments.
With over 600 allogeneic clinical trials currently underway, the pressure to secure high-quality, consistent donor-derived starting material has never been greater. This summit provides a unique opportunity to explore how smarter donor screening, recruitment, and retention strategies can directly impact product quality, manufacturing scalability, and clinical success.
Attendees will gain actionable insights into:
- Donor testing and screening protocols that improve product safety and consistency
- Retention strategies to build reliable donor pools
- Cryobiology and supply chain innovations that enhance cell viability and streamline logistics
- Analytical development and quality control for robust characterization of the starting material
See what other insights you can walk away with in the program: https://ter.li/c2h7ym
The summit features expert speakers from leading organizations, including Bristol Myers Squibb, Genentech, Allogene Therapeutics, ImmuneBridge, NKILT, Luminary Therapeutics, and many more, offering a cross-functional perspective on how donor and source decisions shape the future of cell therapy.
Unlike broader cell therapy conferences, this event zeroes in on the upstream decisions that define downstream success. Whether you're optimizing donor engagement, navigating regulatory complexities, or refining your sourcing strategy, the Donor Selection & Cell Source Summit provides the tools and connections to move your program forward.
Expect two days of deep scientific exchange, strategic discussion, and collaborative problem-solving in an intimate setting designed to foster meaningful dialogue. If you're working to unlock the full potential of allogeneic therapies, this is the one event you can't afford to miss.
For more information on the Summit, view the program: https://ter.li/c2h7ym
